Correlation Between Cidara Therapeutics and Galera Therapeutics
Can any of the company-specific risk be diversified away by investing in both Cidara Therapeutics and Galera Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cidara Therapeutics and Galera Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cidara Therapeutics and Galera Therapeutics, you can compare the effects of market volatilities on Cidara Therapeutics and Galera Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cidara Therapeutics with a short position of Galera Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cidara Therapeutics and Galera Therapeutics.
Diversification Opportunities for Cidara Therapeutics and Galera Therapeutics
-0.48 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Cidara and Galera is -0.48. Overlapping area represents the amount of risk that can be diversified away by holding Cidara Therapeutics and Galera Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Galera Therapeutics and Cidara Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cidara Therapeutics are associated (or correlated) with Galera Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Galera Therapeutics has no effect on the direction of Cidara Therapeutics i.e., Cidara Therapeutics and Galera Therapeutics go up and down completely randomly.
Pair Corralation between Cidara Therapeutics and Galera Therapeutics
If you would invest 1,303 in Cidara Therapeutics on September 5, 2024 and sell it today you would earn a total of 468.00 from holding Cidara Therapeutics or generate 35.92% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 4.55% |
Values | Daily Returns |
Cidara Therapeutics vs. Galera Therapeutics
Performance |
Timeline |
Cidara Therapeutics |
Galera Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Cidara Therapeutics and Galera Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Cidara Therapeutics and Galera Therapeutics
The main advantage of trading using opposite Cidara Therapeutics and Galera Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cidara Therapeutics position performs unexpectedly, Galera Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Galera Therapeutics will offset losses from the drop in Galera Therapeutics' long position.Cidara Therapeutics vs. CytomX Therapeutics | Cidara Therapeutics vs. Clearside Biomedical | Cidara Therapeutics vs. GlycoMimetics |
Galera Therapeutics vs. Mereo BioPharma Group | Galera Therapeutics vs. Terns Pharmaceuticals | Galera Therapeutics vs. PDS Biotechnology Corp | Galera Therapeutics vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Complementary Tools
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |